Clinic
University of Texas Medical Branch at Galveston
University of Texas Medical Branch at Galveston was paid $21K by Medicaid between Sep 2021 and Sep 2021, across 14 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoUNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
GALVESTON, TX 77555
GALVESTON, TX 77555
33aNPI1821054883assigned 04/26/2006
33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center
28Total paid$21K
24GClaims504
24DCodes billed14
24AFirst – last monthSep 2021 – Sep 2021
Compared with peers
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Texas
Rank by total paid#85 of 373
Median peer was paid$734.46
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 504 | $21K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 164 | 161 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 18% | 96 | 56 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 23 | 23 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.1% | 26 | 25 | $2K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 7.7% | 24 | 24 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.6% | 24 | 24 | $550.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.4% | 13 | 13 | $512.93 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.4% | 13 | 13 | $512.93 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.4% | 23 | 15 | $508.20 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.5% | 13 | 13 | $319.62 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 28 | 27 | $219.37 |
| 86780 | <1% | 12 | 12 | $164.59 |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOUTON, CHARLES (PRESIDENT AD INTERIM)